Given the following molecule represented by the SMILES string: Cc1ccc(C(=O)[NH+]2CC[NH+](C3c4cccc5cccc(c45)C3NS(=O)(=O)c3ccccc3)CC2)cc1, and the following genes: ABCB1,ABL1,ADRA1D,ADRA2B,ADRB2,CA12,CA2,CA9,CACNA1H,CDK2,CHRM1,CHRM3,CHRM4,CNR1,CYP1A2,CYP2C19,CYP2C9,CYP2D6,CYP3A4,DRD2,DRD3,DRD4,EGFR,ESR1,FLT1,HRH1,HTR1A,HTR2A,HTR2B,HTR2C,HTR6,KCNH2,KDR,LCK,MCL1,OPRK1,PPARG,PTGS1,SIGMAR1,SLC6A2,SLC6A4, describe whether the molecule is related to one or a few of these genes in clear, simple and accurate English. Explain the relationship between the molecule and the related genes in detail. You can break down by explain the patterns of the molecule, followed by the gene features. Format the output as 'Step 1:', 'Step 2:', etc., with each step focusing on a specific aspect of the molecule's structure or properties. Finally, summarize the related gene names in a list. Limit the reasoning to at most 5 steps. You can stop after summarizing the related gene names. Do not provide any additional information.
Step 1: The molecule contains a quinoline ring system, which is a common pharmacophore found in various drugs targeting G-protein coupled receptors (GPCRs). This structural feature suggests potential interactions with GPCRs.
Step 2: The molecule also includes a pyridine ring and a benzene ring, which are known to interact with certain enzymes such as cytochrome P450s (CYPs). These rings are involved in the binding sites of CYP enzymes, indicating possible metabolic pathways involving the molecule.
Step 3: The presence of a phenyl group and an amide group in the molecule may suggest interaction with proteins involved in signal transduction pathways. Specifically, this could be relevant for genes encoding receptors that respond to neurotransmitters and hormones.
Step 4: The molecule’s structure hints at its ability to bind to ion channels, given the presence of a carboxamide group and a cyclic amide moiety. This is indicative of potential interactions with genes encoding voltage-gated ion channels.
Step 5: Based on the identified structural features, the molecule may be related to the following genes: ADRA1D, ADRA2B, ABL1, CYP1A2, CYP2C9, CYP2D6, CYP3A4, DRD2, HTR1A, HTR2A, HTR2B, KCNH2, LCK, MCL1, PTGS1, SLC6A2, SLC6A4. Step 1: The molecule contains a quinoline ring system, which is a common pharmacophore found in various drugs targeting G-protein coupled receptors (GPCRs).
Step 2: The molecule also includes a pyridine ring and a benzene ring, which are known to interact with certain enzymes such as cytochrome P450s (CYPs).
Step 3: The presence of a phenyl group and an amide group in the molecule may suggest interaction with proteins involved in signal transduction pathways.
Step 4: The molecule’s structure hints at its ability to bind to ion channels, given the presence of a carboxamide group and a cyclic amide moiety.
Step 5: Based on the identified structural features, the molecule may be related to the following genes: ADRA1D, ADRA2B, ABL1, CYP1A2, CYP2C9, CYP2D6, CYP3A4, DRD2, HTR1A, HTR2A, HTR2B, KCNH2, LCK, MCL1, PTGS1, SLC6A2, SLC6A4. 
Summary of related gene names: ADRA1D, ADRA2B, ABL1, CYP1A2, CYP2C9, CYP2D6, CYP3A4, DRD2, HTR1A, HTR2A, HTR2B, KCNH2, LCK, MCL1, PTGS1, SLC6A2, SLC6A4.
